Epimedokoreanin B

• Description:

  Epimedokoreanin B (EKB), an isoprenylated flavonoid isolated from Korean Epimedium, exhibited anticancer activity in human non-small cell lung cancer (NSCLC) A549 and NCI-H292 cells.Epimedokoreanin B also possesses anti-inflammatory and antibacterial activities, and may have scavenging activity against DPPH radicals, inhibiting the proliferation of MCF-7 and HepG2 in a dose-dependent manner. Epimedokoreanin B also exhibits anti-inflammatory and antibacterial activity, with DPPH radical scavenging activity, and inhibits the proliferation of MCF-7 and HepG2 in a dose-dependent manner.Epimedokoreanin B significantly inhibits the formation of N (α) - (carboxymethyl) lysine (CML) and N (Ï) - (carboxymethyl) arginine (CMA), and prevents clinical complications of diabetes mellitus through the inhibition of advanced glycation end-products (AGEs) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  422.47

• Molecular Formula:

  C25H26O6

• Notes:

  Research use only, not for human use.

• Receptor:

  Apoptosis | Antibacterial

• CAS Number:

  161068-53-7